Shanghai / Nijmegen / Verona / Rotterdam / Milano / The Hague / Athens / Munich / Halsteren / Rhein / Milan / Ingelheim / /
Company
Boehringer-Ingelheim Pharmaceuticals / GlaxoSmithKline / IMS Health / Boehringer Ingelheim GmbH / EuroQol Group / /
Continent
Asia / /
Country
Germany / Netherlands / Italy / Sweden / Belgium / France / United States / United Kingdom / China / /
Currency
EUR / /
Facility
GlaxoSmithKline spa / Viersprong Institute / University of Milan / Erasmus University Medical Center / /
IndustryTerm
potential solutions / medical technology assessment / satellite study / imaging / earlystage medical technology assessment / stroke care / in performing earlystage medical technology assessment / /
European International Society for Pharmacoeconomics / Department for Medical Psychology and Psychotherapy / University of Milan / Milan / Erasmus University Medical Center Rotterdam / Erasmus University Medical Center / Centre of Pharmacoeconomics / Institute for Medical Technology Assessment / Radboud University Nijmegen Medical Centre / Congress / European International Society for Pharmacoeconomics and Outcomes Research / Viersprong Institute for Studies / Outcomes Research / Department for Medical Psychology and Psychotherapy at Erasmus University Medical Center / /
Person
Leona Hakkaart-van / Centre / Jan van Busschbach / Robert Welte / Maureen Rutten-van / Andrea Pitrelli / Paul Krabbe / Authors Maiwenn Al / Jennifer Gaultney / Mark Oppe / Ken Redekop / Jan Bakker / Maureen Rutten-van Mölken / Claus Neurohr / Brigitta Monz / Lucas Goossens / Authors Mark Oppe / Luciana Scalone / Jörg Martin / /
Position
physician / Researcher / Scientist / Research Associate / existing probabilistic cost-effectiveness model / Associate professor of Health Economics / Professor / Associate professor / /
Vol. 5, Nr. 2, OctoberiMTA@ISPOR Athens This special issue of the iMTA Newsletter provides you with a complete overview of the activities of iMTA at the Annual European